JAK/STAT signaling in hepatocellular carcinoma

Liver cancer is the second most lethal cancer in the world with limited treatment options. Hepatocellular carcinoma (HCC), which accounts for more than 80% of all liver cancers, has had increasing global incidence over the past few years. There is an urgent need for novel and better therapeutic inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Hin Tang, Justin Jit, Hao Thng, Dexter Kai, Lim, Jhin Jieh, Toh, Tan Boon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137178/
https://www.ncbi.nlm.nih.gov/pubmed/32273976
http://dx.doi.org/10.2217/hep-2020-0001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137178/
https://www.ncbi.nlm.nih.gov/pubmed/32273976
http://dx.doi.org/10.2217/hep-2020-0001

Ejemplares similares